SI1560827T1 - Antiinfekcijska sredstva - Google Patents
Antiinfekcijska sredstvaInfo
- Publication number
- SI1560827T1 SI1560827T1 SI200331953T SI200331953T SI1560827T1 SI 1560827 T1 SI1560827 T1 SI 1560827T1 SI 200331953 T SI200331953 T SI 200331953T SI 200331953 T SI200331953 T SI 200331953T SI 1560827 T1 SI1560827 T1 SI 1560827T1
- Authority
- SI
- Slovenia
- Prior art keywords
- compound
- hcv
- inhibiting
- processes
- polymerase
- Prior art date
Links
- 229960005475 antiinfective agent Drugs 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 241000711549 Hepacivirus C Species 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/285,714 US20040097492A1 (en) | 2002-11-01 | 2002-11-01 | Anti-infective agents |
| US10/410,853 US20040087577A1 (en) | 2002-11-01 | 2003-04-10 | Anti-infective agents |
| US10/625,121 US20040162285A1 (en) | 2002-11-01 | 2003-07-23 | Anti-infective agents |
| US10/679,881 US20050075331A1 (en) | 2003-10-06 | 2003-10-06 | Anti-infective agents |
| EP03768559A EP1560827B1 (en) | 2002-11-01 | 2003-10-31 | Anti-infective agents |
| PCT/US2003/034707 WO2004041818A1 (en) | 2002-11-01 | 2003-10-31 | Anti-infective agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1560827T1 true SI1560827T1 (sl) | 2011-04-29 |
Family
ID=43426110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331953T SI1560827T1 (sl) | 2002-11-01 | 2003-10-31 | Antiinfekcijska sredstva |
Country Status (6)
| Country | Link |
|---|---|
| JP (2) | JP4738172B2 (https=) |
| AT (1) | ATE493408T1 (https=) |
| DE (1) | DE60335564D1 (https=) |
| DK (1) | DK1560827T3 (https=) |
| PT (1) | PT1560827E (https=) |
| SI (1) | SI1560827T1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA100120C2 (en) * | 2007-04-03 | 2012-11-26 | Анадис Фармасьютикалз, Инк. | 5,6-dihydro-1h-pyridin-2-one compounds |
| GB0800855D0 (en) * | 2008-01-17 | 2008-02-27 | Syngenta Ltd | Herbicidal compounds |
| MX2010011307A (es) * | 2008-04-15 | 2010-11-09 | Intermune Inc | Nuevos inhibidores de la replicacion del virus de hepatitis c. |
| US8338337B2 (en) * | 2008-10-29 | 2012-12-25 | Basf Se | Substituted pyridines having a herbicidal effect |
| MX2011008641A (es) * | 2009-03-06 | 2011-09-06 | Hoffmann La Roche | Compuestos heterociclicos antivirales. |
| JP2013525368A (ja) * | 2010-04-23 | 2013-06-20 | キネタ・インコーポレイテツド | 抗ウイルス性化合物 |
| MY183704A (en) * | 2011-06-07 | 2021-03-09 | Anadys Pharmaceuticals Inc | [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001085172A1 (en) * | 2000-05-10 | 2001-11-15 | Smithkline Beecham Corporation | Novel anti-infectives |
| AR036081A1 (es) * | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
| WO2003059356A2 (en) * | 2001-10-30 | 2003-07-24 | Smithkline Beecham Corporation | Novel anti-infectives |
-
2003
- 2003-10-31 AT AT03768559T patent/ATE493408T1/de active
- 2003-10-31 DE DE60335564T patent/DE60335564D1/de not_active Expired - Lifetime
- 2003-10-31 DK DK03768559.1T patent/DK1560827T3/da active
- 2003-10-31 JP JP2005502238A patent/JP4738172B2/ja not_active Expired - Fee Related
- 2003-10-31 SI SI200331953T patent/SI1560827T1/sl unknown
- 2003-10-31 PT PT03768559T patent/PT1560827E/pt unknown
-
2011
- 2011-02-18 JP JP2011033491A patent/JP5250649B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006509042A (ja) | 2006-03-16 |
| PT1560827E (pt) | 2011-03-17 |
| DK1560827T3 (da) | 2011-04-18 |
| JP4738172B2 (ja) | 2011-08-03 |
| DE60335564D1 (de) | 2011-02-10 |
| ATE493408T1 (de) | 2011-01-15 |
| JP2011144183A (ja) | 2011-07-28 |
| JP5250649B2 (ja) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2361913A8 (en) | Anti-infective agents | |
| WO2007076034A3 (en) | Anti-viral compounds | |
| WO2007081517A8 (en) | Anti-viral compounds | |
| WO2007076035A3 (en) | Anti-viral compounds | |
| BR0305259A (pt) | Inibidores de hcv ns5b polimerase | |
| AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
| WO2004009020A3 (en) | Pyrrolopyrimidine thionucleoside analogs as antivirals | |
| EE05709B1 (et) | Nukleosiidhend, seda sisaldav farmatseutiline kompositsioon ning hendi kasutamine viiruse RNA-s?ltuva RNA polmeraasi inhibiitorina toimiva ravimi valmistamiseks | |
| MY140680A (en) | Hepatitis c virus inhibitors | |
| TW200518746A (en) | Novel inhibitors of hepatitis C virus NS3/NS4A serine protease | |
| WO2005054430A3 (en) | Hepatitis c virus inhibitors | |
| PT1680137E (pt) | Ácidos carboxílicos macrocíclicos e acilsulfonamidas como inibidores da replicação do vhc | |
| DK1521754T3 (da) | Virale inhibitorer | |
| IS8448A (is) | Lifrarbólgu C-veirutálmar | |
| WO2008057875A3 (en) | Inhibitors of hepatitis c virus | |
| BR0110023A (pt) | Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite | |
| SI1719773T1 (sl) | Kondenzirane heterotetraciklične spojine in njihova uporaba kot inhibitorji polimeraze HCV | |
| AP1771A (en) | 3'-Prodrugs of 2'-deoxy-?-L-nucleosides. | |
| BR0115447A (pt) | Inibidores de tripeptìdeo de hepatite c | |
| BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
| EP1435974A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS C VIRUS USING 4 'MODIFIED NUCLEOSIDES | |
| ID27787A (id) | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan | |
| TW200505944A (en) | Crystalline phases of a potent HCV inhibitor | |
| PL376409A1 (en) | Composition for the treatment of infection by flaviviridae viruses | |
| AU2002343556A1 (en) | Use of phosphonate nucleotide analogue for treating hepatitis b virus infections |